Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02912130Not ApplicableCompleted

Exercise and Nutrition Interventions in Age-related Sarcopenia

Role: lead

NCT06217640Active Not Recruiting

Multivariate Biomarker Study for Sarcopenia in Heart Failure

Role: collaborator

NCT06615388Recruiting

Low Energy Availability and Cardiovascular Disease

Role: lead

NCT05708170Phase 4Not Yet Recruiting

Impact of Intravenous Iron on Musculoskeletal Function in Older Adults

Role: lead

NCT04335565Not ApplicableWithdrawn

Stevia Extract and Glucose Homeostasis

Role: lead

NCT04339530Suspended

Vitamin D and Type 2 Diabetes Risk in UK Adults

Role: lead

NCT03285386Not ApplicableCompleted

Priming Exercise in Type 1 Diabetes

Role: lead

NCT03257085Not ApplicableCompleted

CALIBER Phase 1: A Pilot Study in Normal-weight and Overweight Adults.

Role: collaborator

NCT02904980Not ApplicableCompleted

The Effects of a Group-based Gaze Training Intervention for Children With Developmental Coordination Disorder

Role: collaborator

All 9 trials loaded